News Scholar Rock Holding Corporation

Stocks

SRRK

US80706P1030

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-10 EDT			5-day change	1st Jan Change
56.71 ^USD	-2.12%		+3.33%	+28.74%

07-07	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
06-11	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE

All News

Mentions Relevance

06-22	Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD	BU
06-12	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
06-09	Scholar Rock Holding Corporation Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 10:00 AM
05-26	Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference	BU
05-20	Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference	BU
05-15	Scholar Rock reports new employee inducement grants under Nasdaq Listing Rule 5635(c)(4)	RE
05-15	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
05-12	Scholar Rock Holding Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08:00 AM
05-07	Scholar Rock Holding Corporation, Q1 2026 Earnings Call, May 07, 2026
05-07	Scholar Rock Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-07	Scholar Rock Q1 Loss Widens	MT
05-07	Earnings Flash (SRRK) Scholar Rock Posts Q1 Net Loss $0.83 a Share, vs. FactSet Est of $0.80 Loss	MT
05-07	Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights	BU
04-29	Scholar Rock to Present at the BofA Securities 2026 Health Care Conference	BU
04-21	Canaccord Genuity Initiates Scholar Rock at Buy With $62 Price Target	MT
04-21	Scholar Rock Holding Insider Sold Shares Worth $1,517,723, According to a Recent SEC Filing	MT
04-20	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
04-17	Scholar Rock reports new employee inducement grants under Nasdaq Listing Rule 5635(c)(4)	RE
04-17	Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
04-16	Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026	BU
03-31	Scholar Rock Holding Corporation - Special Call
03-31	Scholar Rock Resubmits Biologics License Application For Apitegromab For Treatment Of Children And Adults With Spinal Muscular Atrophy	CI
03-31	Wedbush Adjusts Price Target on Scholar Rock Holding to $58 From $56, Maintains Outperform Rating	MT
03-31	Scholar Rock Resubmits Biologics License Application for Apitegromab to US FDA	MT
03-31	Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)	BU